Literature DB >> 23098696

Open-label, randomized, parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects.

Russell E Poland1, Lev Gertsik, Joya T Favreau, Shawnee I Smith, James M Mirocha, Uma Rao, Eric S Daar.   

Abstract

OBJECTIVES: The study objectives were to determine whether massage therapy reduces symptoms of depression in subjects with human immunodeficiency virus (HIV) disease.
DESIGN: Subjects were randomized non-blinded into one of three parallel groups to receive Swedish massage or to one of two control groups, touch or no intervention for eight weeks. SETTINGS/LOCATION: The study was conducted at the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles, California, which provided primary clinical care in an institutional setting.
SUBJECTS: Study inclusion required being at least 16 years of age, HIV-seropositive, with a diagnosis of major depressive disorder. Subjects had to be on a stable neuropsychiatric, analgesic, and antiretroviral regimen for >30 days with no plans to modify therapy for the duration of the study. Approximately 40% of the subjects were currently taking antidepressants. All subjects were medically stable. Fifty-four (54) subjects were randomized, 50 completed at least 1 week (intent-to-treat; ITT), and 37 completed the study (completers).
INTERVENTIONS: Swedish massage and touch subjects visited the massage therapist for 1 hour twice per week. The touch group had a massage therapist place both hands on the subject with slight pressure, but no massage, in a uniform distribution in the same pattern used for the massage subjects. OUTCOME MEASURES: The primary outcome measure was the Hamilton Rating Scale for Depression score, with the secondary outcome measure being the Beck Depression Inventory.
RESULTS: For both the ITT and completers analyses, massage significantly reduced the severity of depression beginning at week 4 (p ≤ 0.04) and continuing at weeks 6 (p ≤ 0.03) and 8 (p ≤ 0.005) compared to no intervention and/or touch.
CONCLUSIONS: The results indicate that massage therapy can reduce symptoms of depression in subjects with HIV disease. The durability of the response, optimal "dose" of massage, and mechanisms by which massage exerts its antidepressant effects remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098696      PMCID: PMC3627430          DOI: 10.1089/acm.2012.0058

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  29 in total

Review 1.  Moderate pressure is essential for massage therapy effects.

Authors:  Tiffany Field; Miguel Diego; Maria Hernandez-Reif
Journal:  Int J Neurosci       Date:  2010-05       Impact factor: 2.292

2.  Massage therapy attenuates inflammatory signaling after exercise-induced muscle damage.

Authors:  Justin D Crane; Daniel I Ogborn; Colleen Cupido; Simon Melov; Alan Hubbard; Jacqueline M Bourgeois; Mark A Tarnopolsky
Journal:  Sci Transl Med       Date:  2012-02-01       Impact factor: 17.956

3.  Moderate pressure massage elicits a parasympathetic nervous system response.

Authors:  Miguel A Diego; Tiffany Field
Journal:  Int J Neurosci       Date:  2009       Impact factor: 2.292

4.  The use of complementary and alternative therapies to treat anxiety and depression in the United States.

Authors:  R C Kessler; J Soukup; R B Davis; D F Foster; S A Wilkey; M I Van Rompay; D M Eisenberg
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

Review 5.  Treatment effects of massage therapy in depressed people: a meta-analysis.

Authors:  Wen-Hsuan Hou; Pai-Tsung Chiang; Tun-Yen Hsu; Su-Ying Chiu; Yung-Chieh Yen
Journal:  J Clin Psychiatry       Date:  2010-03-23       Impact factor: 4.384

6.  Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

Authors:  J R Ickovics; M E Hamburger; D Vlahov; E E Schoenbaum; P Schuman; R J Boland; J Moore
Journal:  JAMA       Date:  2001-03-21       Impact factor: 56.272

Review 7.  Treatment of depression in diabetes: impact on mood and medical outcome.

Authors:  Patrick J Lustman; Ray E Clouse
Journal:  J Psychosom Res       Date:  2002-10       Impact factor: 3.006

8.  Ethnic differences in antidepressant response: a prospective multi-site clinical trial.

Authors:  Ira M Lesser; Hector F Myers; Keh-Ming Lin; Consuelo Bingham Mira; Nataria T Joseph; Natasha T Olmos; Jonathan Schettino; Russell E Poland
Journal:  Depress Anxiety       Date:  2010       Impact factor: 6.505

Review 9.  Depression in patients with HIV infection.

Authors:  S R Penzak; Y S Reddy; S R Grimsley
Journal:  Am J Health Syst Pharm       Date:  2000-02-15       Impact factor: 2.637

Review 10.  HIV and depression: 2008 review and update.

Authors:  Judith G Rabkin
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

View more
  4 in total

Review 1.  Control interventions in randomised trials among people with mental health disorders.

Authors:  Erlend Faltinsen; Adnan Todorovac; Laura Staxen Bruun; Asbjørn Hróbjartsson; Christian Gluud; Mickey T Kongerslev; Erik Simonsen; Ole Jakob Storebø
Journal:  Cochrane Database Syst Rev       Date:  2022-04-04

Review 2.  Massage therapy research review.

Authors:  Tiffany Field
Journal:  Complement Ther Clin Pract       Date:  2016-04-23       Impact factor: 2.446

3.  Perceptions of Massage Therapists Participating in a Randomized Controlled Trial.

Authors:  Adam Perlman; Mark Dreusicke; Teresa Keever; Ather Ali
Journal:  Int J Ther Massage Bodywork       Date:  2015-09-01

4.  Supportive effect of body contact care with ylang ylang aromatherapy and mobile intervention team for suicide prevention: A pilot study.

Authors:  Stéphane Amadéo; Ngoc Lam Nguyen; Taivini Teai; Patrick Favro; Aurélia Mulet; Nathalie Colin-Fagotin; Moerani Rereao; Aurélia Malogne; Michel De Simone; Géraldine Rioche; Virginie Gassion; Paul Pere; Alban Prokop; Fabienne Bernis; Pierre Dufour; Annie Tuheiava; Germaine Vanquin; Steve Vilhem; Erick Gokalsing; Michel Spodenkiewicz; Marianne Pradem; Monique Seguin; Guy Beauchamp; Pierre Thomas; Guillaume Vaiva; Louis Jehel
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.